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dRIORITY COMMUNICATION
eripheral Inflammation is Associated with Altered
ubstantia Nigra Activity and Psychomotor Slowing
n Humans
ena Brydon, Neil A. Harrison, Cicely Walker, Andrew Steptoe, and Hugo D. Critchley
ackground: Systemic infections commonly cause sickness symptoms including psychomotor retardation. Inflammatory cytokines re-
eased during the innate immune response are implicated in the communication of peripheral inflammatory signals to the brain.
ethods: We used functional magnetic resonance brain imaging (fMRI) to investigate neural effects of peripheral inflammation following
yphoid vaccination in 16 healthy men, using a double-blind, randomized, crossover-controlled design.
esults: Vaccination had no global effect on neurovascular coupling but markedly perturbed neural reactivity within substantia nigra
uring low-level visual stimulation. During a cognitive task, individuals in whom typhoid vaccination engendered higher levels of circulating
nterleukin-6 had significantly slower reaction time responses. Prolonged reaction times and larger interleukin-6 responses were associated
ith evoked neural activity within substantia nigra.
onclusions: Our findings provide mechanistic insights into the interaction between inflammation and neurocognitive performance,
pecifically implicating circulating cytokines and midbrain dopaminergic nuclei in mediating the psychomotor consequences of systemic
nfection.ey Words: Cytokines, fMRI, peripheral inflammation, psychomo-
or slowing, substantia nigra
 n healthy mammals, systemic infections typically engender aset of behavioral, psychological, and physiological changescollectively known as “sickness behavior.” Cognitive and
ffective symptoms include psychomotor retardation, impaired
emory, confusion, decreased motivation (e.g., anorexia, adip-
ia, fatigue), anxiety, and depression (1). Sickness behavior may
e conceptualized as an adaptive reorganization of the host’s
omoeostatic and behavioral priorities to facilitate an immune
esponse, rather than simply a detrimental consequence of
nfection per se (2).
Animal and human studies suggest that inflammatory cyto-
ines play a pivotal role in mediating sickness-related behav-
ors by communicating peripheral inflammation to the brain
 1,3). The rapid activation of tissue macrophages early in the
nnate immune response to infection causes the release of
ytokines interleukin-6 (IL-6), interleukin-1 (IL-1 ), and tu-
or necrosis factor- (TNF- ), along with other proinflamma-
ory mediators. Systemic administration of IL-1 or bacterial
ipopolysaccharide (LPS) (a potent stimulant of cytokine re-
ease) induces sickness symptoms in rodents (1 ). In humans,
ytokine immunotherapy for cancer or hepatitis C frequently
roduces sickness-related symptoms including psychomotor
etardation and depressed mood (3 ). Similarly, elevated circu-
ating IL-6 levels are associated with depressed mood and
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oi:10.1016/j.biopsych.2007.12.007memory deficits in healthy volunteers following peripheral
injection with bacterial endotoxins (4 –6). Peripheral cyto-
kines may access and influence the brain through passive
diffusion (at the level of circumventricular organs and choroid
plexus), active transport (at the level of brain endothelium),
and through the activation of interoceptive afferents, particu-
larly in the vagus nerve, that project to the nucleus of the
solitary tract and higher viscerosensory centers (1 ). Within the
brain, there exists a network of cells that produce cytokines
and express cytokine receptors (1 ), where central cytokine
production can profoundly influence catecholamine neuro-
transmission, synaptic plasticity, and neuronal survival (7 ).
Beyond this evidence, the mechanisms through which pe-
ripheral inflammation engenders sickness-related psychomotor
and behavioral symptoms remain poorly understood. The cur-
rent investigation set out to address these issues by assessing the
impact of a low-grade peripheral immune stimulus, Salmonella
typhi polysaccharide, on cognitive performance and brain activ-
ity in healthy young men.
Methods and Materials
Study Population
Sixteen male student volunteers between 18 and 35 years of
age were recruited from University College London. Volunteers
were screened by structured interview to ensure that they were
healthy, had no previous history of any relevant physical or
psychiatric illness, were taking no medication, and were non-
smokers. Volunteers who had received typhoid vaccine in the
past 3 years or any other vaccine in the previous 6 months were
excluded. Participants were advised not to consume caffeinated
beverages or alcohol and to refrain from excessive exercise
during the 12 hours prior to testing. They were also advised not
to take aspirin, ibuprofen, or antibiotics for 14 days prior to
testing. All participants gave their informed consent, and the
study was approved by the joint University College London/
University College London Hospital Committee on the Ethics of
Human Research.
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The study was performed in a double-blind, randomized,
rossover-controlled manner. Participants were assessed individ-
ally in two separate sessions, a mean of 7 days apart. In session
ne, a baseline blood sample was drawn and the participant was
andomly assigned to one of two experimental conditions
typhoid vaccine or placebo). Injections of Salmonella typhi
apsular polysaccharide vaccine (.025 mg in .5 mL; Typhim Vi,
ventis Pasteur S.A., Lyon, France) or control saline placebo (.5
L) were administered intramuscularly into the nondominant
eltoid muscle. Typhoid vaccine was selected as a low-grade
roinflammatory stimulus, since this vaccine is known to induce
ncreases in circulating proinflammatory cytokine levels with no
ignificant effect on body temperature, a potentially confounding
actor (4). To investigate the effect of peripheral inflammation on
ognitive and cerebral function, participants performed two tasks
uring simultaneous functional magnetic resonance brain imag-
ng. The first was a low-grade visual stimulation task and the
econd was a mentally challenging color-word Stroop task. Tasks
ere performed 2 hours postinjection, around the time of peak
ytokine responses to typhoid vaccine (8). A second blood
ample was drawn after scanning (at 3 hours postinjection) for
ssessment of inflammatory cytokines. Subjective ratings of
ood and illness symptoms were taken at baseline, 2 hours, and
hours, and body temperature was assessed using a sublingual
igital thermometer. The second session was identical to the first
xcept that participants were injected with saline placebo if they
ad received typhoid vaccine in session one or vice versa.
ssessment of Mood and Illness Symptoms
Mood and symptoms of illness were assessed with a modified,
6-item version of the Profile of Mood States (POMS) (9), as
escribed previously (4). Six high-loading items were taken from
he vigor, tension-anxiety, depression-dejection, and confusion
cales of the original POMS, and five items were taken from the
atigue scale. Four extra items were added to assess symptoms
ssociated with mild infection (fever, aching joints, nausea, and
eadache). Participants were asked to rate how they felt at that
oment on a 5-point scale from 0  not at all to 4  extremely.
ow-Grade Visual Stimulation Task
First, to test for a general perturbation of neurovascular
oupling during systemic inflammation, each participant under-
ent a low-level visual stimulation task involving the intermittent
resentation of a high-contrast flickering black and white check-
rboard stimulus (Figure 1). The stimulus was presented in
lternating blocks of 21.6 seconds (on) and 15.1 seconds (off).
igure 1. High-contrast flashing checkerboard task used as a potent stimu-
us of primary visual cortical regions. Participants fixated on a cross at the
enter of the screen and pressed a keywhenever the brightness of the cross
hanged.A total of 20 on blocks and 20 off blocks were presented in two
sessions of 6.4 minutes. Participants responded with a right-
handed button press to changes in the brightness of a central
fixation cross, ensuring attention to the center of the screen. This
low-level visual stimulation paradigm is known to induce potent
blood oxygenation level-dependent (BOLD) responses in striate
and extrastriate visual cortices (V1; Brodmann areas 17 and 18).
Color-Word Stroop Task
Participants performed a second task during fMRI, the color-
word Stroop task (Figure 2). This is a very well established task
for assessing high-demand cognitive processing, including atten-
tional and executive control processes, via effects of stimulus
conflict on psychomotor responses. These functions are known
to be compromised by sickness. The task requires the participant
to name the ink color of word stimuli, in this case by making a
four-choice button press response. The target color word was
presented with four possible response words (red, yellow, green,
and blue) below. Target words and the order of response words
were displayed randomly. Participants were instructed to re-
spond as rapidly as possible to the color of the target word, using
a four-button response pad corresponding to the response words
below. In the congruent condition, the font color of all words
matched both the ink color and semantic meaning of the target
word, whereas in the incongruent condition, words were printed
in a color incongruent with the color and meaning of the target
word. Thus, in incongruent trials, the participant had to over-
come distraction from the meaning of the target and ink color of
the response choices (Figure 2). Both targets and response words
were displayed for 3000 msec, preceded by a central fixation
cross presented for 2000 msec. No feedback was given. Trials
were presented in five blocks of 36 events with 10,000-msec
breaks between blocks. The percentage of incongruent trials
varied between blocks and ranged from 14% (two blocks), 28%
(one block), to 42% (two blocks), with 17% null events per block.
Functional Magnetic Resonance Imaging
Functional magnetic resonance imaging (fMRI) was per-
formed using a 1.5T Siemens Sonata magnetic resonance scanner
(Siemens, Erlangen, Germany) equipped with a standard head
coil. Mild external head restraint was used to minimize head
movement during scanning. Visual stimuli were projected onto a
Figure 2. Cognitive color-word Stroop task. Participants pressed a key to
select the response word that correctly identified the print color of the
target word. Congruent and incongruent conditions were presented sepa-
rately and examples of these are illustrated here. In the congruent example
(upper panel), the correct response is green. In the incongruent example,
requiring greater cognitive effort (lower panel), the correct response is red.screen visible via a mirror on the head coil. Functional brain
www.sobp.org/journal
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wmaging data were acquired using T2*-weighted echoplanar
maging, sensitive to BOLD contrast. For the visual checkerboard
aradigm, the sequence had 24 contiguous slices 2 mm thick, 1
m interslice gap, no tilt, echo time (TE) 40 msec, and repetition
ime (TR) 2.16 sec per volume. Three hundred fifty-six volumes
ere acquired for each participant in two sessions of 6.4 minutes.
or the Stroop task, data were acquired with whole-brain cover-
ge using a sequence with 44 contiguous slices, 2 mm slice
hickness, 1 mm interslice gap, tilted30° from intercommissural
lane, TE 40 msec, and TR 3.96 sec per volume (10). Two
undred forty-eight volumes were acquired for each participant
n a single session of 16.4 minutes.
ytokine Analysis
Separate venipunctures were performed at baseline and at 3
ours postvaccination. Blood (10 mL) was drawn into Vacutainer
ubes (Becton Dickinson Diagnostics, Oxford, United Kingdom)
ontaining EDTA as anticoagulant, then centrifuged immediately
t 1250g for 10 minutes at room temperature. Plasma was
emoved, aliquoted, and frozen at 70°C prior to analysis.
lasma concentrations of IL-6 and TNF- were assessed using
igh-sensitivity enzyme-linked immunosorbent assays (ELISAs)
rom R&D Systems (Oxford, United Kingdom). The limits of
etection of these assays were .09 pg/mL (IL-6) and .10 pg/mL
TNF-), respectively. Plasma interleukin-1 receptor antagonist
IL-1Ra) concentrations were determined by a commercial ELISA
rom R&D Systems (Oxford, United Kingdom), with a detection
imit of 15 pg/mL. All assays had interassay and intra-assay
oefficients of variation (CVs) of less than 10%.
tatistical Analyses
Cytokine levels were analyzed using repeated measures anal-
sis of variance, with treatment (vaccine, placebo) and sample
baseline, postscan) as within-subject factors.
The association between the IL-6 response to vaccine/stress,
alculated as the mean increase between baseline and posttask,
nd mean reaction time (RT) was analyzed using product
oment correlations.
Functional MRI datasets were analyzed using SPM5 (Statistical
arametric Mapping [SPM], Wellcome Trust Centre for Neuroim-
ging, Institute of Neurology, UCL, London, United Kingdom;
ttp://www.fil.ion.ucl.ac.uk/spm). The first five volumes were
iscarded to allow for T1 equilibration effects. Individual scans
ere realigned and unwarped, time-corrected, normalized, and
patially smoothed with an 8-mm full width at half maximum
FWHM) Gaussian kernel using SPM methods. A high-pass
requency filter (cutoff 120 sec) and corrections for autocorrela-
ion between scans (AR1) were applied to the time series.
In the visual checkerboard condition, stimulation blocks
checkerboard on; 10 volumes) and rest blocks (checkerboard
ff; 7 volumes) were modeled as separate regressors. Contrasts
f stimulation greater than rest were produced for each subject
or both vaccine and placebo conditions and compared within a
econd level analysis using paired t tests. Results for the check-
rboard task in primary visual areas are reported at a very liberal
hreshold of p  .01 uncorrected. In analysis of the Stroop task,
ach event was modeled by a standard synthetic hemodynamic
esponse function at each voxel across the whole brain. Congru-
nt and incongruent trials and errors of commission (response
ithin 3 seconds) and omission (response after 3 seconds) errors
ere modeled as separate regressors in first-level multiple re-
ression analysis. In the experimental design (see above), null
vents were included to facilitate identification of differential
emodynamic responses to stochastically ordered stimuli.
ww.sobp.org/journalThe first-level individualized design matrices for each partic-
ipant were estimated within the general linear model. Effects of
task (incongruent and congruent) were computed on a voxel-
wise basis for each participant for both vaccination and placebo
conditions in the form of statistical parametric maps of discrete
contrasts. Subsequent second-level paired t test analyses were
performed on the SPM contrast images for formal inference about
population effects. Between-subject effects of mean reaction
time and inflammatory response indexed by vaccine-induced
change in IL-6 were then determined using regression analysis.
Results
Inflammatory Cytokine Response to Vaccination
Across participants, typhoid vaccination evoked a robust inflam-
matory response with a greater than twofold increase in plasma IL-6
from .66  .38 pmol/L at baseline to 1.66  .86 pmol/L at 3 hours
(p .001) (Figure 3). The placebo condition evoked amuch smaller
rise in IL-6 (.60  .41 pmol/L at baseline to .87  .63 pmol/L at 3
hours, p .05) (Figure 3), consistent with a physiological response
to experimental stress (11). There was a significant treatment by
sample (baseline and at 3 hours) interaction for IL-6 (F  7.98, p 
.013). Increases in plasma TNF- or IL-1Ra did not reach signifi-
cance, consistent with previous findings (4). There was also no
significant effect of vaccination on participants’ core body temper-
ature.
Subjective Response to Vaccination
Vaccination, but not placebo, enhanced subjective ratings of
fatigue (p  .01) and mental confusion (p  .01). There was no
effect of vaccine on ratings of illness symptoms, including fever,
aching joints, nausea, and headache, and no relationship be-
tween cytokine responses and any subjective ratings.
Peripheral Inflammation and Neural Reactivity During Low-
Level Visual Stimulation
As intended, the checkerboard task potently activated early
visual cortices in all participants, measured by changes in BOLD
signal in V1, reflecting regional vascular reactions coupled to
changes in evoked neural activity. Importantly, we observed no
Figure 3.Cytokine response to typhoid vaccination. A high-sensitivity, two-
site ELISA was used to measure plasma concentrations of IL-6 in blood
samples drawn at the beginning of each session (baseline) and 3 hours
following intramuscular injection with either typhoid vaccine or normal
saline placebo (postscan). Data are presented as the mean increase in pico-
grams of IL-6 per milliliter of plasma  SEM in vaccine (solid line) and
placebo (dashed line) conditions (*p .001,n 16; significant treatment by
sample interaction, F  7.98, p  .013). ELISA, enzyme-linked immunosor-
bent assay; IL-6, interleukin-6.
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L. Brydon et al. BIOL PSYCHIATRY 2008;63:1022–1029 1025ifferences in the magnitude of the BOLD responses in early
isual cortices during inflammation (typhoid vaccine) compared
ith placebo conditions, indicating no general effect of inflam-
ation on neurovascular coupling (Figure 4A). However, we
bserved a highly robust (yet unpredicted) inflammation-related
hange in neural reactivity within the substantia nigra during
isual stimulation (Figure 4B). The differential response of the
ubstantia nigra to visual (compared with no visual) stimulation
as attenuated in the vaccine condition compared with the
lacebo condition (Supplement 1). It is noteworthy that this
ffect was left lateralized, since participants were making right-
anded responses during the task.
eripheral Inflammation and Reaction Time Performance on
ognitive Stroop Task
All participants demonstrated significant increases in re-
igure 4. Effect of peripheral inflammation on neural reactivity during low-
rade visual stimulation task. (A)Mean BOLD signal change (SEM) during
heckerboard stimulus in all voxels probabilistically assigned to Brodmann
reas 17 and18 for vaccine andplacebo conditions. Therewasno significant
nteraction between mean activation to visual stimulation and inflamma-
ory state in either BA17 (p .11) or BA18 (p .34), confirming no effect of
nflammation on neurovascular coupling. (B) Interaction between task per-
ormanceand inflammatory state showsahighly significant change inBOLD
ignalwithin the left substantia nigra duringperformance of flashing check-
rboard task (p .002afterwholebrain family-wiseerror [FWE] correctionat
 .05). BA, Brodmann area; BOLD, blood oxygenation level-dependent;
WE, family-wise error.ponse time and number of errors on the incongruent comparedwith the congruent Stroop task trials [mean RT difference SE
377.6 msec  21.6, t (23)  17.46, p  .001; mean difference
errors SE 4.21 .66, t (23) 6.38, p .001]. Vaccination did
not affect behavioral measures of Stroop task performance; there
were no significant differences in either response time (p 0.31)
or number of errors (p  0.79) between typhoid vaccine and
placebo conditions. Nevertheless, in the vaccine condition only,
the levels of IL-6 (mean increase from baseline) strongly pre-
dicted reaction times to both congruent and incongruent Stroop
stimuli (vaccine; r  .82, p  .001, placebo; p  .253, ns),
indicating that participants with a larger inflammatory (IL-6)
response to typhoid vaccine had significantly prolonged reaction
time responses (Figure 5). Interestingly, there was no interaction
with the degree of stimulus conflict, such that IL-6–related slowing
of reaction time for the harder incongruent trials was of the same
magnitude as that observed in the easier congruent trials (incongru-
ent trials: r .72, p .006, congruent trials: r .83, p .001). Thus,
following vaccination, the level of the inflammatory cytokine IL-6
predicted a general slowing of motor response to stimuli. Moreover,
the lack of a superadded effect on responses to incongruent stimuli
suggests a precognitive influence of inflammation on response. Due
to a paucity of response errors (mean number errors 4 out of 180
trials per session), we were unable to demonstrate a significant
relationship between error and IL-6 levels. Reaction time slowing
did not correlate significantly with subjective ratings of mood or
illness symptoms.
Relationship Between Neural Reactivity, Reaction Time
Performance, and Peripheral Inflammation
We quantified regional brain activity reflecting stimulus pro-
cessing (both congruent and incongruent stimuli) during the
Stroop task in both the vaccine and placebo conditions. We next
performed a correlational analysis to determine brain regions
that were more activated in individuals with greater IL-6 re-
sponses. Participants with a greater IL-6 response to typhoid
vaccine demonstrated enhanced neural responses to Stroop
Figure 5. Relationship between IL-6 response to typhoid vaccine and reac-
tion time performance on Stroop task. Scatter plot illustrating themean key
press reaction time in milliseconds (congruent and incongruent conditions
grouped) as a function of themeanplasma IL-6 response to typhoid vaccine
(increase between baseline and 3 hours) (r  .82, p  .001). IL-6, interleu-
kin-6.
www.sobp.org/journal
s
p
s
I
i
c
b
s
i
a
F
t
a
i
(
i
s

b
i
1026 BIOL PSYCHIATRY 2008;63:1022–1029 L. Brydon et al.
wtimuli within left substantia nigra (p  .001, Figure 6A) (Sup-
lement 2). The correlation of left substantia nigra BOLD re-
ponse (8 mm region of interest centered on the peak voxel) with
L-6 response to typhoid vaccine (r  .67, p  .005) is illustrated
n Figure 6B. No such relationship was observed in the placebo
ondition (p  .68).
We then performed a similar analysis of the relationship
etween Stroop task-related activity and individuals’ mean re-
ponse times. Our brain imaging analysis across participants
dentified a significant correlation between reaction time slowing
Illustrated at 
P < 0.005
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igure 6. IL-6 response to typhoid vaccine predicts enhanced neural activa-
ion within left substantia nigra during Stroop task performance. (A) fMRI
nalysis revealed heightened BOLD activity within left substantia nigra dur-
ng performance of the cognitive Stroop task in the vaccine condition
threshold p  .001, illustrated at p  .005 uncorrected). (B) Scatter plot
llustrating the relationship between substantia nigra activity (BOLD re-
ponsewithin an 8mm region of interest centered on the peak voxel atMNI
12,2,8) and mean IL-6 response to typhoid vaccine (p .005). BOLD,
lood oxygenation level-dependent; fMRI, functional magnetic resonance
maging; IL-6, interleukin-6; MNI, Montreal Neurological Institute.nd BOLD activity changes within the same region of left
ww.sobp.org/journalsubstantia nigra (Figure 7A and 7B; region-of-interest analysis:
r .60, p .03). These findings further implicated the substantia
nigra midbrain region in the psychomotor consequences of
inflammation. No such relationship was observed in the placebo
condition (p  .71). Again, due to a paucity of response errors,
we were unable to demonstrate a predictive relationship be-
tween regional neural (including substantia nigra) activity and
performance error on the Stroop task. There was also no
correlation between substantia nigra activity and subjective
ratings of mood or illness symptoms. It is noteworthy that the
location of activity changes within substantia nigra reflecting
both IL-6 response and psychomotor slowing was rostral to the
more robust effect observed during checkerboard stimulation.
This observation suggests a functional topographical organiza-
Figure 7. Enhanced substantia nigra activity predicts reaction time slowing.
Mean response time on the cognitive Stroop task was significantly corre-
latedwith neural activity in the same left substantia nigra region of interest.
(A)Amplified image of BOLD response in left SN that covariedwith reaction
time in the vaccine condition. (B) Scatter plot illustrating the relationship
between substantia nigra activity (BOLD responsewithin an 8mm region of
interest centered on the peak voxel atMNI12,2,8) andmean reaction
time in typhoid vaccine condition (p .03). BOLD, blood oxygenation level-
dependent; MNI, Montreal Neurological Institute; SN, substantia nigra.
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L. Brydon et al. BIOL PSYCHIATRY 2008;63:1022–1029 1027ion (behavioral versus perceptual) within the same dopaminer-
ic midbrain nucleus.
iscussion
This is the first empirical study to directly address the neural
echanisms underlying the psychomotor consequences of pe-
ipheral inflammation. Our findings provide objective evidence
or a relationship between changes in substantia nigra function
nd generation of sickness symptoms, notably psychomotor
etardation, as a consequence of peripheral inflammation. Sub-
tantia nigra activity to performance of a simple motor task
button press) during both low-level visual stimulation and
ognitive task performance was modulated by peripheral inflam-
atory challenge. For the cognitive Stroop task, this effect was
ost apparent in people with larger inflammatory IL-6 responses
o typhoid vaccine, and both IL-6 responses and activity within
ubstantia nigra predicted a precognitive prolongation of motor
eaction. The directionality of these effects is noteworthy. During
he checkerboard stimulation task, presented and analyzed as a
locked design, inflammation attenuated the normal decrease in
OLD signal within substantia nigra. During the Stroop task,
nalyzed in an event-related manner (i.e., coupled more directly
ith motor responses), substantia nigra signal increased with
ncreased reaction time. Although the structure of both tasks is
ery different, it would appear that the greater BOLD signal
eflects a functional perturbation within substantia nigra, the
etailed mechanisms of which are presently beyond the resolu-
ion of fMRI.
The substantia nigra is a midbrain nucleus, integral to the basal
anglia system, and the major source of dopamine in the brain. The
igrostriatal dopamine pathway is pivotal in the facilitation of
ovement, signaling of stimulus salience, and driving motivational
ehavior (12–14). Nigral dopaminergic projection neurons release
opamine within striatal target regions in response to salient stimuli
o modulate sensorimotor processing and representations of incen-
ive value across cerebral cortices, thalamus, and amygdala (15).
gonists that potentiate dopaminergic neurotransmission im-
rove the speed of motor responses in animals, whereas striatal
opamine depletion and selective blockade of dopamine D1 or
2 receptors significantly impair performance on reaction time
asks (13,16,17). Similar to our findings, impaired task perfor-
ance is due to lengthened response latencies rather than
eficits in the accuracy of responses, suggestive of a reduction in
otivation versus ability to perform (16,17). However, central
eural changes related to performance errors have been noted in
atients receiving interferon- (IFN-) therapy (18). In healthy
lderly humans, lower levels of striatal dopamine transporter are
ssociated with slower motor reactions (19), while the loss of
igrostriatal dopaminergic neurons in human Parkinson’s disease
esults in severe deficits in the initiation of motor behavior that
an be alleviated with dopaminergic medication (20). Our results
xtend these observations by implicating the substantia nigra in
sychomotor components of sickness behavior mediated by
nflammatory cytokines.
Elevated circulating cytokines are associated with psychomo-
or dysfunction in both animal models and humans. In rodents,
ystemic administration of bacterial LPS or inflammatory cyto-
ines (notably IL-1) consistently suppresses locomotor and
otivational behaviors, resulting in increased periods of immo-
ility, decreased operant responding for food rewards, and social
ithdrawal (1). These depressant effects of peripheral IL-1 on
ehavior are potentiated by IL-6 (21). The motor-suppressingeffects of inflammatory challenge are reduced by administration
of antibodies against IL-6 (22,23) and attenuated in IL-6 knockout
mice (24). Our data suggest that the behavioral effects of
peripheral inflammation in humans are mediated by altered
dopaminergic neurotransmission. Correspondingly, in rodents,
brain dopamine levels are modulated by peripheral administra-
tion of IFN- (a potent inducer of IL-6) and other inflammatory
cytokines (25,26). Human patients receiving immunotherapy
with IFN- experience psychomotor slowing and fatigue (3).
These symptoms correlate with abnormalities in striatal glucose
metabolism, suggesting dysregulation of dopaminergic signaling
(27). Elevated circulating IL-6, altered striatal dopaminergic neu-
rotransmission, and psychomotor slowing are also reported in
people with clinical depression (28,29). Our novel findings
provide direct empirical evidence in humans for involvement of
the dopamine system in behavioral consequences of peripheral
inflammation, highlighting a role for IL-6 and substantia nigra
neural activity in infection-related psychomotor impairments.
Sickness behavior can be considered as the expression of a
centrally mediated motivational state that reorganizes the organ-
ism’s priorities to promote survival (2). Thus, during an infection,
psychomotor slowing may minimize energy expenditure and
conserve heat, thereby enhancing immune function. Accord-
ingly, cytokine-induced sickness is reflected in a reduction in the
number of lever presses that rats will make to obtain a sucrose
reward (30). These motivational changes are mirrored in dopam-
ine-depleted rats, which also reduce lever pressing for a pre-
ferred food while increasing intake of concurrently available lab
chow, thereby reorienting to less effortful food-seeking behav-
iors (31). Such a failure to sustain behavioral effort in animals that
can still initiate normal responding indicates a change in the
representation of incentive salience (13). In humans, dopamine
antagonists can impair reward-related responses within ventral
striatum and diminish behavioral effort to obtain reward (32).
Similar motivational deficits occur in patients with Parkinson’s
disease (13). Our current findings suggest that changes in
motivation and incentive salience integral to sickness behavior
may, like changes in motor reactivity, arise from inflammation-
induced alterations in dopaminergic neuromodulation originat-
ing in substantia nigra.
Brain systems controlling behavior may be influenced by
peripheral inflammation and cytokines via a set of discrete
routes, including activation of vagus nerve or spinal cord intero-
ceptive afferents, passive diffusion of cytokines into cerebrospi-
nal fluid in regions that lack a blood-brain barrier, or active
transport across the brain endothelium via cytokine-specific
transport molecules (1). Evidence in rodents implicates vagus
nerve afferents in the rapid central communication of early
inflammatory responses and the modulation of sickness behav-
iors (33–35). Cytokine receptors are expressed by macrophages
and dendritic cells that cluster around vagus nerve perineural
sheaths (36) and on vagus nerve sensory afferent terminals such
that circulating cytokines can stimulate vagus nerve activity (36).
Lipopolysaccharide-mediated induction of peripheral inflamma-
tion in rats causes a rapid (within 60 minutes) activation of the
primary central projection area of the vagus nerve (nucleus
tractus solitarius [NTS]) and subsequent activation of secondary
vagus nerve projection areas including parabrachial, paraven-
tricular, and hypothalamic nuclei, amygdala, and bed nucleus of
the stria terminalis (33). Vagotomy attenuates this distributed
neural response to peripheral inflammatory challenge and blocks
corresponding sickness behaviors (34). These data suggest the
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wagus nerve is important in the early central communication of
nflammatory responses observed in the present study.
Animal models demonstrate that chronic peripheral inflam-
ation may also lead to the expression of inflammatory cyto-
ines in microglia within brain stem nuclei including the NTS
33–35). These responses are normally short-lived and tightly
egulated by anti-inflammatory cytokines and endogenous glu-
ocorticoids (1). However, in certain neurodegenerative condi-
ions, cytokine-producing microglia may become primed, result-
ng in exaggerated inflammatory responses that promote neural
amage and behavioral deficits (37–40). The substantia nigra
ontains the greatest density of microglia within the brain and
ay thus be particularly vulnerable to the consequences of
hronic inflammatory responses (41). Microglial activation and
ytokine release within substantia nigra precede neural cell loss in
odent models of Parkinson’s disease and correlate with indices of
isease progression in human patients with Parkinson’s disease
42–44). Our own observations of acute inflammation-induced
lteration in the functional integrity of the substantia nigra, related to
eripheral cytokine response and psychomotor changes, further
ighlight an intrinsic vulnerability of this region to the effects of
nflammation.
Taken together, our findings provide mechanistic insights into
he interaction between inflammation and neurocognitive per-
ormance, implicating circulating cytokines and midbrain dopa-
inergic nuclei in mediating the psychomotor consequences of
ystemic infection. Understanding the mechanisms that link
eripheral immune stimuli with neural activity and psychological
ell-being is fundamental to the development of interventions
imed at controlling the behavioral and depressive symptoms
hat develop during infection and represent a common comor-
idity of inflammatory diseases as diverse as atherosclerosis,
besity, and cancer. Our findings may also be clinically relevant
o understanding mechanisms through which systemic inflam-
ation can exacerbate behavioral deficits and disease progres-
ion in neurodegenerative disorders such as Parkinson’s disease.
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